Jump to section
Chronicled's mission is to provide administration and build solutions on top of the MediLedger Network to facilitate trust and enable automation between trading partners.
-7% employee growth in 12 months
The life sciences industry relies on trading partnerships, and this requires a level of trust to operate smoothly. Chargeback errors, contract disputes, and data sharing can all complicate trading relationships, and this can cause operational friction and stunt revenue for both parties.
Chronicled provides a blockchain-powered B2B trust and automation platform for the life sciences industry, offering a product called MediLedger designed to automate contract communication and updating, claim adjudication and roster management to improve chargeback accuracy and data privacy. In addition to preventing contract disputes, the platform also includes a tool for sub-second prescription drug verification.
Whilst contract automation tools exist for many sectors such as construction and real estate, Chronicled has identified the need for a bespoke solution within the life sciences industry. By leveraging blockchain to emphasize contractual obligation and using automation to minimize chargeback errors or disputes, the company claims its platform can help strengthen trading relationships, streamline operations, and optimize revenue for both parties.
Steph
Company Specialist at Welcome to the Jungle
Feb 2022
$8.3m
EARLY VC
Jan 2019
$16m
SERIES A
This company has top investors
Ryan Orr
(Chairman)Experience as Co-founder of Zanbato. Executive Director and Associate Consulting Professor for Stanford University from 2005 to 2015.
Maurizio Greco
(CTO)VP of Engineering and CTO of Finantix from 2002 to 2012. Experience as CTO of TheBankCloud.